US Broker Ratings

Evolent Health, Inc. (EVH) Stock Analysis: Exploring a 164.92% Potential Upside in Healthcare Innovation

Evolent Health, Inc. (NYSE: EVH) is a compelling name in the healthcare sector, particularly in the health information services industry. Specializing in specialty care management services across oncology, cardiology, and..

NeoGenomics, Inc. (NEO) Stock Analysis: Growth Potential and Investor Insights

NeoGenomics, Inc. (NYSE: NEO) is carving a significant niche in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $1.59 billion, this U.S.-based company..

U.S. Physical Therapy, Inc. (USPH) Stock Analysis: Exploring a 25.91% Potential Upside in the Healthcare Sector

U.S. Physical Therapy, Inc. (NYSE: USPH) stands out in the healthcare sector, particularly within the medical care facilities industry, with its robust growth trajectory and a promising upside potential for..

Astrana Health Inc. (ASTH) Stock Analysis: Exploring a 60.79% Potential Upside

For investors seeking opportunities in the healthcare sector, Astrana Health Inc. (ASTH) presents a compelling case with its considerable potential upside of 60.79%. As a healthcare management company based in..

Arcellx, Inc. (ACLX) Stock Analysis: Unveiling A 61.73% Potential Upside in Biotechnology

Arcellx, Inc. (NASDAQ: ACLX) stands out in the biotechnology sector with its innovative approach to immunotherapy, aiming to tackle some of the most challenging cancer forms. With a market capitalization..

BioLife Solutions, Inc. (BLFS) Stock Analysis: A 45% Potential Upside Awaits Investors

For investors eyeing the healthcare sector, BioLife Solutions, Inc. (NASDAQ: BLFS) presents itself as a promising opportunity with a projected potential upside of 45.3%. Specializing in innovative bioproduction products and..

Alphatec Holdings, Inc. (ATEC) Stock Analysis: Unveiling a 69.88% Upside Potential in the Medical Devices Sector

Alphatec Holdings, Inc. (ATEC), a prominent player in the healthcare sector, specifically in the medical devices industry, is drawing significant attention from investors due to its promising upside potential. With..

Ardent Health, Inc. (ARDT) Stock Analysis: A 52.11% Potential Upside with a Strong Buy Consensus

Investors looking for opportunities in the healthcare sector might find Ardent Health, Inc. (NYSE: ARDT) an intriguing choice. As a prominent player in the medical care facilities industry, Ardent Health..

Indivior Pharmaceuticals (INDV) Stock Analysis: A 30% Upside Opportunity Amidst Promising Drug Innovations

Indivior Pharmaceuticals, Inc. (INDV), a leading player in the healthcare sector specializing in the development of buprenorphine-based prescription drugs, is capturing investor attention with its robust pipeline and a compelling..

Aurinia Pharmaceuticals Inc (AUPH) Stock Analysis: Uncovering the 9.51% Potential Upside

Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) is capturing investor attention with its focused approach in the biotechnology sector, specializing in treatments for autoimmune diseases. As of today, the stock trades at..

Progyny, Inc. (PGNY) Stock Analysis: Healthcare Innovator Offers 27.67% Potential Upside

Progyny, Inc. (NASDAQ: PGNY), a leading player in the healthcare sector, is capturing the attention of investors with its innovative approach to fertility and women’s health benefits. With a substantial..

Pediatrix Medical Group, Inc. (MD) Stock Analysis: Exploring a 5.72% Potential Upside

Pediatrix Medical Group, Inc. (NYSE: MD), a prominent player in the healthcare sector, operates within the medical care facilities industry, specializing in newborn and maternal-fetal care services across the United..

Clover Health Investments, Corp (CLOV): Investor Outlook on a 46.97% Potential Upside

Clover Health Investments, Corp (CLOV) is stirring interest in the healthcare sector, particularly within the healthcare plans industry, where it seeks to revolutionize Medicare Advantage through its innovative Clover Assistant..

MiMedx Group, Inc. (MDXG) Stock Analysis: Unpacking a 104% Potential Upside for Investors

MiMedx Group, Inc. (NASDAQ: MDXG) stands out as a noteworthy opportunity in the biotechnology sector, offering an impressive potential upside of over 104% according to current analyst ratings. With a..

Belite Bio, Inc (BLTE) Stock Analysis: Strong Buy Ratings and Promising Clinical Pipeline Signal Growth Potential

Belite Bio, Inc (NASDAQ: BLTE) is capturing investor attention with its compelling clinical pipeline and robust market performance. As a clinical-stage biopharmaceutical company, Belite Bio is focused on developing novel..

Zai Lab Limited (ZLAB)

⚠️ No article content returned.

..

Healthcare Services Group, Inc. (HCSG) Stock Analysis: Evaluating an 11.8% Potential Upside

Healthcare Services Group, Inc. (NASDAQ: HCSG) is garnering attention in the medical care facilities industry, offering an intriguing investment opportunity for those eyeing the healthcare sector. With its current market..

Recursion Pharmaceuticals (RXRX) Stock Analysis: Biotech Innovator with 67% Potential Upside

Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) is emerging as a notable player in the biotechnology sector, with a market capitalization of $2.18 billion. Based in Salt Lake City, Utah, the company..

Opko Health, Inc. (OPK) Stock Analysis: Exploring a Potential 177.99% Upside in the Diagnostics and Pharmaceuticals Sector

Opko Health, Inc. (OPK), a key player in the healthcare sector, is garnering attention from investors due to its substantial potential upside. Trading on the stock exchange at a current..

Amneal Pharmaceuticals, Inc. (AMRX) Stock Analysis: Navigating Growth with a Promising Revenue Surge in the Healthcare Sector

As a prominent player in the healthcare sector, Amneal Pharmaceuticals, Inc. (NYSE: AMRX) has carved a niche in the competitive landscape of drug manufacturing, specializing in both generic and specialty..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds